marcus evans europe conferences

10th Annual Biologics Formulation Development and Drug Delivery Forum

Enhance the Efficiency of your Formulation Process, Achieve High-concentration while Ensuring Stability, Implement the Latest Control Strategies and Discuss Novel Delivery Systems

15-17 May 2019
Hotel Melià Madrid Serrano, Madrid, Spain

Conference Workshop

Achieve Stability, High Concentration, and Excellent Manufacturing Systems

This workshop will focus on discussing and assessing tools to tackle formulation challenges such as protein aggregates, protein characterization or particulate matter. Participants will be able to dive into a real case study to understand the potential of mass spectrometry to acknowledge the characterisation of biopharmaceutical higher order structure and conformational dynamics.

Workshop Moderator: Tudor Arvinte

Company: Professor at the School of Pharmacy at University of Geneva & CEO at Therapeomics Inc


Why You Should Attend

10th Annual Biologics Formulation Development and Drug Delivery Forum

This annual marcus evans industry-working group will feature many of the ongoing constraints that are faced during the formulation development of biologics and the selection and development of drug delivery systems. From protein characterisation to QbD practices and manufacturing processes, this event will enable you to grasp the latest research, learn about novel innovative delivery platforms and be part of highly interactive discussions. Experts in the field from Big Pharma companies, Research Institutes and successful Biotech companies will lead this engaging upcoming event. We will foster stimulating conversations by creating a platform to discuss high-concentrated formulations, challenges with excipient interactions, liquid and powder formulations, several delivery systems or the feasibility of oral biologics. 

This annual event will feature manifold topics; we will be discussing the feasibility of novel delivery systems, the advances for the next generation of biologics, the use of nanoparticles for different purposes, a toolbox for a robust formulation process and how to master fill-finish manufacturing.


Key Topics

  • Queen’s University Belfast presenting protein-excipients interactions, nanoparticles by microfluidics and ocular delivery systems.
  • Alexion Pharmaceuticals assessing parenteral versus subcutaneous delivery
  • MedImmune discussing fusion proteins formulation and other novel modalities
  • Boehringer Ingelheim showcasing the best strategy to obtain a high concentrated formula
  • Previous Attendees Include

    • GlaxoSmithKline
    • Pfizer
    • Abbvie
    • Roche Biologics
    • UCB
    • Sandoz
    • Abbott
    • Baxter
    • Novartis Vaccines
    • Sanofi aventis
    • Boehringer Ingelheim
    • Medimmune
    • Bayer
    • Bristol-Myers Squibb
    • Genentech
    • Janssen Pharmaceutical
    • Merck & Co
    • Novo Nordisk
    • University of Cambridge


    Why Choose marcus evans?

    marcus evans specialises in the research and development of strategic events for senior business executives. From our international network of 63 offices, marcus evans produces over 1000 event days a year on strategic issues in corporate finance, telecommunications, technology, health, transportation, capital markets, human resources and business improvement.

    Above all, marcus evans provides clients with business information and knowledge which enables them to sustain a valuable competitive advantage and makes a positive contribution to their success.


    Event Sponsors
    Visit website >>
    Visit website >>


    Event Partners


    Practical Insights From

    Tanya Mezhebovsky
    Associate Director Pharmaceutical Development
    Alexion Pharmaceuticals

    Patrick Garidel
    Head of Process, Purification and Pharmaceuticals Development
    Boehringer Ingelheim

    Andrea Hawe
    Chief Scientific Officer
    Coriolis Pharma

    Dimitrios Lamprou
    Professor in Pharmaceutical Engineering
    Queen’s University Belfast

    Robert Liebner
    Principal Scientist Parenterals
    Merck

    Fethi Bensaid
    Section Head Formulation & Process Development
    Sanofi

    Adrian Podmore
    Late Stage Formulation Scientist
    MedImmune

    Saif Shubber
    Formulation Team Leader
    Ipsen

    Click Here For Full Agenda

    Voice of Our Customers
    • “The conference was very interesting – all the topics presented have been very useful!”, Genzyme
    • “Really enjoyed the speakers & interactivity of the event!”, Ipsen
    • “One of the best meetings I’ve attended. Excellent organisation, topics and speakers”, GSK
    • “High quality agenda and fantastic speakers, I would definitely attend again”, Roche
    Latest Conference News & Resources



    Join the Discussion

    Follow on LinkedIn





    Event Contact

    For all enquiries regarding speaking, sponsoring and attending this conference contact:

    Constandinos Vinall


    marcus evans (Europe) Ltd
    PO Box 24797
    1304 Nicosia, Cyprus

    Telephone:
    +357 22849 380
    Fax: +357 22849 394
    Email: constandinosv@marcusevanscy.com